Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Early B Cell Factor 1 (EBF1) Regulates Glomerular Development by Controlling Mesangial Maturation and Consequently COX-2 Expression.

Nelson T, Velazquez H, Troiano N, Fretz JA.

J Am Soc Nephrol. 2019 Aug 12. pii: ASN.2018070699. doi: 10.1681/ASN.2018070699. [Epub ahead of print]

PMID:
31405952
2.

Bone marrow adipocytes.

Horowitz MC, Berry R, Holtrup B, Sebo Z, Nelson T, Fretz JA, Lindskog D, Kaplan JL, Ables G, Rodeheffer MS, Rosen CJ.

Adipocyte. 2017 Jul 3;6(3):193-204. doi: 10.1080/21623945.2017.1367881. Epub 2017 Aug 24. Review.

3.

Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue.

Gao H, Mejhert N, Fretz JA, Arner E, Lorente-Cebrián S, Ehrlund A, Dahlman-Wright K, Gong X, Strömblad S, Douagi I, Laurencikiene J, Dahlman I, Daub CO, Rydén M, Horowitz MC, Arner P.

Cell Metab. 2014 Jun 3;19(6):981-92. doi: 10.1016/j.cmet.2014.03.032. Epub 2014 May 22.

4.

Use of osmium tetroxide staining with microcomputerized tomography to visualize and quantify bone marrow adipose tissue in vivo.

Scheller EL, Troiano N, Vanhoutan JN, Bouxsein MA, Fretz JA, Xi Y, Nelson T, Katz G, Berry R, Church CD, Doucette CR, Rodeheffer MS, Macdougald OA, Rosen CJ, Horowitz MC.

Methods Enzymol. 2014;537:123-39. doi: 10.1016/B978-0-12-411619-1.00007-0.

5.

Early B-cell factor 1 is an essential transcription factor for postnatal glomerular maturation.

Fretz JA, Nelson T, Velazquez H, Xi Y, Moeckel GW, Horowitz MC.

Kidney Int. 2014 May;85(5):1091-102. doi: 10.1038/ki.2013.433. Epub 2013 Oct 30.

6.

Sclerostin: A new mediator of crosstalk between the skeletal and immune systems.

Horowitz MC, Fretz JA.

J Bone Miner Res. 2012 Jul;27(7):1448-50. doi: 10.1002/jbmr.1672. No abstract available.

7.

How B cells influence bone biology in health and disease.

Horowitz MC, Fretz JA, Lorenzo JA.

Bone. 2010 Sep;47(3):472-9. doi: 10.1016/j.bone.2010.06.011. Epub 2010 Jun 18. Review.

8.

Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse.

Fretz JA, Nelson T, Xi Y, Adams DJ, Rosen CJ, Horowitz MC.

Endocrinology. 2010 Apr;151(4):1611-21. doi: 10.1210/en.2009-0987. Epub 2010 Feb 19.

9.

Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

DuSell CD, Nelson ER, Wittmann BM, Fretz JA, Kazmin D, Thomas RS, Pike JW, McDonnell DP.

Mol Endocrinol. 2010 Jan;24(1):33-46. doi: 10.1210/me.2009-0339. Epub 2009 Nov 9.

10.

Ebf1-dependent control of the osteoblast and adipocyte lineages.

Hesslein DG, Fretz JA, Xi Y, Nelson T, Zhou S, Lorenzo JA, Schatz DG, Horowitz MC.

Bone. 2009 Apr;44(4):537-46. doi: 10.1016/j.bone.2008.11.021. Epub 2008 Dec 16.

11.

Molecular actions of 1,25-dihydroxyvitamin D3 on genes involved in calcium homeostasis.

Pike JW, Zella LA, Meyer MB, Fretz JA, Kim S.

J Bone Miner Res. 2007 Dec;22 Suppl 2:V16-9. doi: 10.1359/jbmr.07s207. Review.

13.

Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass.

Galli C, Zella LA, Fretz JA, Fu Q, Pike JW, Weinstein RS, Manolagas SC, O'Brien CA.

Endocrinology. 2008 Jan;149(1):146-53. Epub 2007 Oct 11.

14.
15.

Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.

Pike JW, Meyer MB, Watanuki M, Kim S, Zella LA, Fretz JA, Yamazaki M, Shevde NK.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):389-95. Epub 2007 Jan 12.

16.

Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3.

Kim S, Yamazaki M, Zella LA, Meyer MB, Fretz JA, Shevde NK, Pike JW.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):430-4. Epub 2007 Jan 2.

Supplemental Content

Loading ...
Support Center